Response to the letter to the editor: “Methodological considerations in the evaluation of pain and central sensitization in lipedema”

Abstract

Get full access to this article

View all access options for this article.

References

Sakızli Erdal

Haspolat

Ergin

, et al. A multidimensional evaluation of pain in lipedema. Phlebology. 2026; 2683555261427251. https://doi.org/10.1177/02683555261427251

Turk

Dworkin

Burke

, et al. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain 2006; 125(3): 208–215. https://doi.org/10.1016/j.pain.2006.09.028

Neblett

Sanabria-Mazo

Luciano

, et al. Is the Central Sensitization Inventory (CSI) associated with Quantitative Sensory Testing (QST)? A systematic review and meta-analysis. Neurosci Biobehav Rev 2024; 161: 105612. https://doi.org/10.1016/j.neubiorev.2024.105612

Patel

Amtmann

Jensen

, et al. Clinical outcome assessment in clinical trials of chronic pain treatments. Pain Reports 2021; 6(1): e784. https://doi.org/10.1097/PR9.0000000000000784

Canning

Bartholomew

. Lipedema. Vasc Med 2018; 23(1): 88–90. https://doi.org/10.1177/1358863X17739698